Lineage (LINE) opened Q1 2026 with revenue of US$1.3 billion and a basic EPS loss of US$0.20. On a trailing 12 month basis, revenue stood at US$5.4 billion and basic EPS was a loss of US$0.63, alongside trailing 12 month revenue growth of 4.6% a year versus 11.3% for the broader US market. Over recent quarters, revenue has moved in a narrow band between US$1.29 billion and US$1.38 billion, while quarterly basic EPS has ranged from a loss of US$0.44 to a small profit of roughly US$0.03. This leaves investors weighing modest top line growth against ongoing losses and pressure on margins.

See our full analysis for Lineage.

With the latest results on the table, the next step is to set these numbers against the key narratives around Lineage to see which views hold up and which need a rethink.

Losses Persist Despite US$5.4b In Sales

• On a trailing 12 month basis, Lineage generated about US$5.4b of revenue but reported net income losses of US$144 million and a basic EPS loss of US$0.63.
• Bulls point to catalysts like growing fresh and frozen food demand and a US$167 million EBITDA target from 25 ramping facilities. However, the trailing 12 month loss and a 4.6% revenue growth rate versus 11.3% for the US market highlight that the business has not yet translated these growth ideas into positive earnings.
  • Consensus narrative expects revenue to grow around 3.5% a year, while the trailing 12 month history shows the company still unprofitable with losses widening about 15.7% a year over five years.
  • This mix of steady revenue and continued losses means any bullish view needs to be comfortable with a period of negative EPS even as the project pipeline and LinOS efficiency gains are rolled out.

Stay curious about how the bullish case stacks up against these loss figures by reviewing what optimistic investors are focusing on today 🐂 Lineage Bull Case.

FFO Turns Positive While EPS Stays Negative

• Funds From Operations swung to a trailing 12 month positive of US$245 million at Q1 2026, even as basic EPS over the same period was a loss of US$0.63 and net income was a loss of US$144 million.
• Bulls argue that cash style metrics like FFO and expected EBITDA from new facilities matter more for a REIT than near term EPS. The positive US$245 million FFO plus US$167 million targeted incremental EBITDA from 25 developments partly supports that view, although the negative EPS shows accounting earnings are still under pressure.
  • Quarterly FFO has ranged from a loss of US$11 million to a profit of US$91 million over the last few reported periods, which lines up with the idea of a business in transition rather than one with settled cash generation.
  • The bullish view that productivity tools like LinOS can reduce a US$1.5b annual labor bill sits against this mixed FFO history, so it is worth watching whether FFO stabilizes as deployments increase.

Deep Valuation Discount Against Ongoing Losses

• Lineage trades on a P/S of 1.6x versus peers at 10.7x and the Global Industrial REITs average of 8.7x, and the DCF fair value of US$58.67 sits well above the current US$37.81 share price.
• Bears highlight that the company remains unprofitable and is expected to stay loss making for at least three years. The combination of trailing 12 month net losses of US$144 million, a 5.58% dividend that is not covered by earnings, and a slower 4.6% revenue growth rate compared with 11.3% for the US market backs up that cautious stance even with the apparent valuation discount.
  • Analysts' consensus target of US$41.21 is only modestly ahead of the current price, which is much closer than the gap implied by the DCF fair value and suggests the market is treating the low P/S and DCF gap carefully in light of the earnings track record.
  • Given the dividend is not well covered by current earnings, income focused investors may pay more attention to the persistent losses than to the low P/S multiple alone.

If you want to see why some investors stay cautious despite the low P/S multiple and DCF gap, take a closer look at the key concerns shaping the skeptical view 🐻 Lineage Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Lineage on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Seen enough mixed signals to feel torn on Lineage? Act while the details are fresh and weigh both sides by reviewing the 2 key rewards and 2 important warning signs.

See What Else Is Out There

Lineage combines US$5.4b in trailing revenue with ongoing net and EPS losses, slower revenue growth than the broader US market, and a dividend not covered by earnings.

If you are uneasy about that mix of losses and uncovered income, you may want to shift your focus toward financially sturdier ideas. You can do this by checking companies in the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.